https://www.selleckchem.com/pr....oducts/glumetinib.ht
Patients in the low-risk group were more likely to have higher tumor mutational burden, stem cell characteristics, and higher PD-L1 expression levels. Furthermore, a genomic-clinicopathologic nomogram was established and shown to be a more effective risk stratification tool than any clinical parameter alone. This study demonstrated the prognostic value of LMRG and showed that they may be partially involved in the suppressive immune microenvironment formation. This study demonstrated the prognostic value of LMRG and showed that they m
Like
Comment
Share
